Entry
Name
Proteoglycans in cancer - Felis catus (domestic cat)
Description
Many proteoglycans (PGs) in the tumor microenvironment have been shown to be key macromolecules that contribute to biology of various types of cancer including proliferation, adhesion, angiogenesis and metastasis, affecting tumor progress. The four main types of proteoglycans include hyaluronan (HA), which does not occur as a PG but in free form, heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), dematan sulfate proteoglycans (DSPG) and keratan sulfate proteoglycans (KSPGs) [BR:
00535 ]. Among these proteoglycans such as HA, acting with CD44, promotes tumor cell growth and migration, whereas other proteoglycans such as syndecans (-1~-4), glypican (-1, -3) and perlecan may interact with growth factors, cytokines, morphogens and enzymes through HS chains [BR:
00536 ], also leading to tumor growth and invasion. In contrast, some of the small leucine-rich proteolgycans, such as decorin and lumican, can function as tumor repressors, and modulate the signaling pathways by the interaction of their core proteins and multiple receptors.
Class
Human Diseases; Cancer: overview
BRITE hierarchy
Pathway map
Organism
Felis catus (domestic cat) [GN:
fca ]
Gene
100271864 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3 [KO:K02649 ]
101080675 PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X2 [KO:K05859 ] [EC:3.1.4.11 ]
101081817 EIF4B; eukaryotic translation initiation factor 4B isoform X3 [KO:K03258 ]
101083892 ARHGEF1; LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 1 [KO:K12330 ]
101084342 CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
101085657 ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532 ]
101086264 VAV2; guanine nucleotide exchange factor VAV2 isoform X7 [KO:K05730 ]
101087179 SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500 ]
101087417 VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730 ]
101087993 ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960 ]
101088695 PLCE1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 isoform X1 [KO:K05860 ] [EC:3.1.4.11 ]
101089624 PPP1R12A; protein phosphatase 1 regulatory subunit 12A isoform X2 [KO:K06270 ]
101091240 PLAUR; urokinase plasminogen activator surface receptor isoform X1 [KO:K03985 ]
101091892 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
101092809 PPP1R12C; protein phosphatase 1 regulatory subunit 12C isoform X1 [KO:K17457 ]
101092925 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116 ] [EC:3.1.4.11 ]
101093069 NUDT16L1; tudor-interacting repair regulator protein isoform X1 [KO:K16867 ]
101093414 TGFB2; transforming growth factor beta-2 proprotein isoform X2 [KO:K13376 ]
101093586 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
101094274 PIK3CD; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922 ] [EC:2.7.1.153 ]
101094520 HSPG2; basement membrane-specific heparan sulfate proteoglycan core protein isoform X1 [KO:K06255 ]
101094530 TIAM1; rho guanine nucleotide exchange factor TIAM1 isoform X1 [KO:K05731 ]
101094772 CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393 ]
101095698 STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692 ]
101097413 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
101098090 CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515 ] [EC:2.7.11.17 ]
101098221 CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X4 [KO:K04515 ] [EC:2.7.11.17 ]
101098615 CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X2 [KO:K04515 ] [EC:2.7.11.17 ]
101098766 PPP1R12B; protein phosphatase 1 regulatory subunit 12B isoform X6 [KO:K12329 ]
101099916 GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364 ]
101100546 ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X2 [KO:K04958 ]
101101230 ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959 ]
101101277 RAC1; ras-related C3 botulinum toxin substrate 1 isoform X3 [KO:K04392 ]
493845 VEGFA; vascular endothelial growth factor A precursor [KO:K05448 ]
493881 FAS; tumor necrosis factor receptor superfamily member 6 precursor [KO:K04390 ]
493943 CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625 ]
493945 FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389 ]
768263 TGFB1; transforming growth factor beta-1 proprotein isoform X2 [KO:K13375 ]
768273 IL12B; interleukin-12 subunit beta precursor [KO:K05425 ]
Compound
G13063 Binding domain for FGF2 in heparin/heparan sulfate
G13064 Binding domain for HGF in heparin/heparan sulfate
Reference
Authors
Bourguignon LY
Title
Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.
Journal
Reference
Authors
Briggs MW, Sacks DB
Title
IQGAP1 as signal integrator: Ca2+, calmodulin, Cdc42 and the cytoskeleton.
Journal
Reference
Authors
Bourguignon LY, Singleton PA, Zhu H, Diedrich F
Title
Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
Journal
Reference
Authors
Bourguignon LY, Gilad E, Rothman K, Peyrollier K
Title
Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
Journal
Reference
Authors
Turley EA, Noble PW, Bourguignon LY
Title
Signaling properties of hyaluronan receptors.
Journal
Reference
Authors
Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC
Title
Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.
Journal
Reference
Authors
Neill T, Schaefer L, Iozzo RV
Title
Decorin: a guardian from the matrix.
Journal
Reference
Authors
Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, Iozzo RV
Title
Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.
Journal
Reference
Authors
Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV
Title
Decorin is a novel antagonistic ligand of the Met receptor.
Journal
Reference
Authors
Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV
Title
Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.
Journal
Reference
Authors
Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV
Title
Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.
Journal
Reference
Authors
Goldoni S, Iozzo RV
Title
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.
Journal
Reference
Authors
Sofeu Feugaing DD, Gotte M, Viola M
Title
More than matrix: the multifaceted role of decorin in cancer.
Journal
Reference
Authors
Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, Tralhao JG, Lemarchand P, Pfeilschifter J, Schaefer RM, Iozzo RV, Schaefer L
Title
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21.
Journal
Reference
Authors
Teng YH, Aquino RS, Park PW
Title
Molecular functions of syndecan-1 in disease.
Journal
Reference
Authors
Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST
Title
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
Journal
Reference
Authors
Fux L, Ilan N, Sanderson RD, Vlodavsky I
Title
Heparanase: busy at the cell surface.
Journal
Reference
Authors
Purushothaman A, Chen L, Yang Y, Sanderson RD
Title
Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.
Journal
Reference
Authors
Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC
Title
Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.
Journal
Reference
Authors
Mahtouk K, Tjin EP, Spaargaren M, Pals ST
Title
The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.
Journal
Reference
Authors
Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M
Title
The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.
Journal
Reference
Authors
Nugent MA, Iozzo RV
Title
Fibroblast growth factor-2.
Journal
Reference
Authors
Baciu PC, Saoncella S, Lee SH, Denhez F, Leuthardt D, Goetinck PF
Title
Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization.
Journal
J Cell Sci 113 Pt 2:315-24 (2000)
Reference
Authors
Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM
Title
ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA.
Journal
Reference
Authors
Beauvais DM, Rapraeger AC
Title
Syndecans in tumor cell adhesion and signaling.
Journal
Reference
Authors
Morgan MR, Humphries MJ, Bass MD
Title
Synergistic control of cell adhesion by integrins and syndecans.
Journal
Reference
Authors
Filmus J, Capurro M, Rast J
Title
Glypicans.
Journal
Reference
Authors
Filmus J, Capurro M
Title
Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
Journal
Reference
Authors
Gao W, Ho M
Title
The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.
Journal
Cancer Rep 1:14-19 (2011)
Reference
Authors
Filmus J, Capurro M
Title
The role of glypicans in Hedgehog signaling.
Journal
Reference
Authors
Cheng W, Tseng CJ, Lin TT, Cheng I, Pan HW, Hsu HC, Lee YM
Title
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
Journal
Reference
Authors
Iozzo RV, Sanderson RD
Title
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
Journal
Reference
Authors
Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN
Title
Lumican, a small leucine-rich proteoglycan.
Journal
Related pathway
fca04810 Regulation of actin cytoskeleton
KO pathway